The LSD1 Inhibitor Ory-1001 (ladademstat) in Combination with Menin Inhibitor SNDX5613 (revumenib) Has Synergistic in Vitro Activity in KMT2A-Rearranged AML ModelsMina M. Tayari,Tulasigeri M. Totiger,Ramin Shiekhattar,Justin Taylor,Justin M. WattsBLOOD(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要